Sharon R Chinthrajah

25PUBLICATIONS
98CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedAllergyEnvironmental epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 12, 2026
Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale-A Major Drawback for Food Allergy Immunotherapy?

S Arasi, F Bärhold, M Alvaro-Lozano

|Nov 04, 2025
Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness.

Xiaorui Han, Valeria Skatova, Artem Mikelov

|Jun 26, 2025
Immune impacts of fire smoke exposure.

Mary M Johnson, Abhinav Kaushik, Olivia A Kline

|Dec 14, 2024
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.

Sayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah

|Dec 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.

R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau

|Sep 23, 2024
Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?

Alessandro Fiocchi, R Sharon Chinthrajah, Ignacio J Ansotegui

Pageof 5

Frequent Collaborators

19 joint publications

Kari Nadeau

9 joint publications

Stephen J Galli

5 joint publications

Andrea Fernandes

4 joint publications

Sandra Andorf